Head CT Without Contrast for Fall Patients on Anticoagulation
For a patient on anticoagulants who has fallen, perform a noncontrast head CT—contrast is not indicated and provides no additional benefit for detecting traumatic intracranial hemorrhage. 1
Why Noncontrast CT is the Standard
The ACR Appropriateness Criteria (2021) explicitly states that noncontrast head CT is the appropriate imaging modality for all acute head trauma evaluation 1. There is no literature supporting the use of contrast-enhanced CT in the initial evaluation of head trauma—contrast adds no diagnostic value for detecting hemorrhage, which is the primary concern in anticoagulated patients who fall.
Key Clinical Decision Points
Coagulopathy (including anticoagulation) is itself an indication for CT imaging according to ACEP guidelines 1:
- Level A recommendation: In patients with loss of consciousness (LOC) or post-traumatic amnesia (PTA), obtain noncontrast head CT if coagulopathy is present (among other criteria)
- Level B recommendation: In patients WITHOUT LOC or PTA, consider noncontrast head CT if coagulopathy is present along with other factors (age ≥65, dangerous mechanism, severe headache, vomiting, focal deficits, GCS <15, or basilar skull fracture signs)
The rationale is straightforward: anticoagulated patients have impaired hemostasis, making them vulnerable to intracranial hemorrhage even from minor trauma. The goal is to detect acute bleeding that could expand and cause neurologic deterioration or death.
What Contrast Would (Not) Add
Contrast-enhanced CT is designed to evaluate:
- Vascular structures (when doing CT angiography)
- Tumor enhancement
- Infection/inflammation
- Blood-brain barrier breakdown
None of these are relevant to acute traumatic hemorrhage detection. Fresh blood appears hyperdense (bright white) on noncontrast CT and is easily visible. Contrast would actually obscure this finding and complicate interpretation, as both blood and contrast appear bright on CT.
After the Initial Scan
Recent evidence shows the risk of delayed hemorrhage in anticoagulated patients with normal initial CT is extremely low:
- Do not routinely perform repeat imaging in patients on anticoagulants with normal initial head CT and baseline neurologic exam 2
- Do not routinely admit or observe these patients if the initial CT shows no hemorrhage and they meet no other criteria for monitoring 2
- One 2026 study of 215 anticoagulated patients with normal head CT found zero cases of delayed intracranial hemorrhage 3
Important Caveats
Repeat imaging IS indicated if:
- New or progressive neurologic deficits develop 1
- Initial CT showed hemorrhage (follow-up to assess progression) 1
- Clinical deterioration occurs
Discharge instructions must include:
- Warning signs of delayed hemorrhage (severe headache, confusion, weakness, seizures, vomiting) 2
- Outpatient referral for fall risk assessment and anticoagulation risk/benefit review 2
Common Pitfalls to Avoid
Don't order contrast "just to be thorough"—it adds radiation exposure, cost, contrast-related risks (nephrotoxicity, allergic reactions), and no diagnostic benefit for trauma
Don't assume all anticoagulated patients need 24-hour observation—the 2023 ACEP guidelines moved away from routine observation if the initial CT is normal 2
Don't confuse CT angiography (CTA) with contrast-enhanced CT—CTA is only indicated if you suspect vascular injury (dissection, pseudoaneurysm) based on mechanism or clinical findings 1
Don't skip the CT entirely in anticoagulated patients who fall—coagulopathy lowers the threshold for imaging even with minimal trauma 1